Clinical Research Associates, Inc.

Have you ever had a stroke, heart attack, cardiac surgery or other cardiac procedure and are interested in losing weight? Or do you have kidney, heart, or vascular disease?

If the answer is yes, then this study may be for you. Click here to learn more.

The purpose of this study is to evaluate the safety and effectiveness of a combination of COVID and FLU in a single injection.  It is thought the combination could increase the likelihood of higher vaccination rates for both viruses.

We are not currently enrolling new patients into this study, but we expect to begin a new round of enrollment in the coming months.

Click here to sign up for updates to hear about when new patients will be enrolled.

Gastroesophageal reflux disease (GERD) is a digestive disease caused by reflux of gastric acid or food into the esophagus.  GERD is classified into erosive esophagitis (EE) and non-erosive reflux disease (NERD).  Both can cause symptoms of heartburn and regurgitation.  EE has changes in the esophageal lining whereas NERD has no changes.  A diagnostic endoscopy is needed to make this determination. Untreated GERD can lead to complications such as bleeding, peptic strictures and could progress to cancer.

This study is not currently enrolling new patients. Click here to sign up for updates.

We are currently coordinating a clinical trial for RSV vaccines for infants. Rather than a traditional needle and shot, this vaccine is administered through a nasal spray. This way, you won't have to worry about poking your little one.

Enrollment for this study is currently paused, but will resume before the next RSV season in 2025.

RSV is one of the leading causes of infant hospitalization, but currently there is no vaccine to protect infants. If you are currently pregnant or have an infant already between 6 and 22 months old, contact us to learn more.

Our migraine studies are temporarily full, and new patients are not currently being added to the study. We expect to begin a new round of enrollment in the coming months. Click here to sign up for our emails and stay up to date.

If you have type 2 diabetes and want to gain better control of your condition and lose excess body weight, then one of these studies may be an option for you. Click on each link to learn more.

1. If you manage your type 2 diabetes with diet and exercise and take no medicine, click here.
2. If you take only metformin to manage your type 2 diabetes, click here.
3. If you take metformin and Insulin, click here.
4. If you take metformin with other medicine (not insulin or an SGLT2 inhibitor), click here.
5. If you take an SGLT2 inhibitor, click here.

The relationship between obesity and Type 2 diabetes is well established.  If you are committed to make a change in your weight and gain better control of your glucose, this research study may be an opportunity for you. All study participants will receive regular diet, physical activity, and lifestyle management counseling sessions throughout the study.

Click here to sign up or for pre-screening or more information